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made, we found that cultured with 0.5, 1.0, 2.0, 4.0, 8.0 mmol/L ho-
mocysteine, cells grew less than cultured with normal culture me-
dium, Cells cultured with homocysteine 4.0 mmol/L for 24h was made
to be the model of injury. To detect the effect of aconine on EAhy926
cell injured by homocysteine, well growing EAhy926 cells were
cultured in culture plate. 24h later, cells were cultured with DMEM
medium containing 2% fetal calf serum for 8 hours to make cells
hungry, then cultured with medium containing aconine 0, 0.05, 0.10,
0.20 mg/ml respectively for 30 minutes, then cultured with medium
containing homocysteine 4.0mmol/L for 24h. It was found that,
compared with control group, attached cells in aconine groups grew
better, and attached cells in aconine 0.20 mg/ml plus homocysteine
4.0 mmol/L group grew best. Detected by nitrate reductase method, it
was found that compared with control group, there was no obvious
change of NO concentration of cell culture ﬂuid in aconine 0.20 mg/ml
group, but in homocysteine 4.0 mmol/L medol group, NO concentra-
tion of cell culture ﬂuid decreased oberviously, and in aconine groups,
NO concentration of cell culture ﬂuid increased, and in aconine
0.20mg/ml plus homocysteine 4.0mmol/L group it was the most
obvious (p <0.05). Detected by Western-blot, it was found that,
compared with control group, there was no obvious change of protein
of Sirt-1 and eNOS inaconine 0.20 mg/ml group, but in homocysteine
4.0 mmol/L model group, expression of Sirt-1 and eNOS protein
weakened obviously, and in aconine groups, expression of Sirt-1 and
eNOS protein enhanced, and in aconine 0.20 mg/ml plus homocyste-
ine 4.0 mmol/L group it was the most obvious (p <0.05). Detected by
ﬂuorescent quantitation, it was found that, compared with control
group, there was no obvious change of mRNA of Sirt -1 and eNOS in
aconine 0.20 mg/ml group, but in homocysteine 4.0mmol/L model
group, expression of Sirt-1 and eNOS mRNA weakened obviously, and
in aconine groups, expression of Sirt-1 and eNOS mRNA enhanced,
and in aconine 0.20 mg/ml Plus homocysteine 4.0 mmol/L group, it
was the most obvious (p <0.05).
CONCLUSIONS Homocysteine may injure EAhy926 cell by suppress-
ing the expression of Sirt-1 then suppressing the expression of eNOS
system, while aconine may protect EAhy926 cell by enhancing the
expression of caveolin-1 then enhancing the expression of eNOS sys-
tem.
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Suv39h1 Promotes Neointima Formation in Diabetes
Jing Chen, Jing Zhang, Changwu Xu, Qi Hu, Shuo Yang, Lin Xu,
Jian Yang, Xiaorong Hu, Hong Jiang
Renmin Hospital of Wuhan University
OBJECTIVES Patients with diabetes are at an increasing risk of
vascular complications. Suv39h1, a histone methyltransferase, is
suggested to protect the vascular smooth muscle cells (VSMCs) from
the metabolic memory and proinﬂammatory phenotype in diabetes
(DM). Yet the direct effects of Suv39h1 on DM-induced vascular
remodeling remain largely elusive.
METHODS In this study, by generating adenovirus expressing
Suv39h1 (Ad-Suv39h1) or lentivirus expressing Suv39h1-targeting
shRNA (LV-Suv39h1 shRNA), we evaluated the signiﬁcance of
Suv39h1, in VSMCs under diabetic conditions both in vitro and in vivo.
In vitro, we examined the proliferative and migratory behavior as well
as the underlying signaling molecules of VSMC in response to high
glucose (30 mM, HG) treatment. In vivo, we induced diabetes in SD
rats with intraperitoneal injection of streptozocin and established the
common carotid artery balloon injury model. Microarray analysis was
performed to identify altered gene proﬁle in carotid arteries after
balloon injury.
RESULTS In response to HG, the endogenous Suv39h1 level was
signiﬁcantly reduced by almost 50% in VSMCs. Following HG treat-
ment, Ad-Suv39h1-infected VSMCs exhibited signiﬁcantly higher
proliferative and migratory capabilities than control group. In
contrast, knocking down Suv39h1 by LV-Suv39h1 shRNA led to
dramatically reduced proliferation and migration. To understand the
molecular mechanisms, knocking down Suv39h1 reduced the levels of
ID3, complement C3 and phosphor-ERK1/2 in response to HG, but
increased the level of p21 and p27KIP1 as compared to control group.
Overexpressing Suv39h1 has the opposite effect on the expression of
these molecules.
Consistent with the in vitro observation, ectopic expression of
Suv39h1 was sufﬁcient to up-regulate complement C3 and ID3 (P <
0.05, as compared to Ad-Null), while knocking down Suv39h1 was
capable of reducing these two molecules in injured vessels (P < 0.05,
as compared to LV-NC shRNA). As we expected, Suv39h1overexpression led to accelerated neointima formation, while
knocking down Suv39h1 reduced it following carotid artery injury in
diabetic rats. Finally, altering Suv39h1 level in vivo dramatically
changed the expressions of myriad genes with various functions and
participating in different biological processes revealed by microarray
analysis. We identiﬁed 233 up-regulated, 221 down-regulated genes
between Ad-Suv39h1 and Ad-Null group, and 849 up-regulated, 658
down-regulated genes between LV-Suv39h1 shRNA and LV-NC shRNA
group. Further Gene Ontology (GO) analysis showed that these altered
genes participated in diverse biological processes, such as metabolic
processes, cell differentiation, cell development, response to external
stimulus.
CONCLUSIONS This study reveals the novel functions of Suv39h1
within VSMC in diabetes and suggests its potential role as a thera-
peutic target for diabetic vascular injury.
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Role of IKKa in high glucose concentration-induced endothelial cell
dysfunction and insulin resistance by IKKa gene silencing
Fanghui Chen
The First Afﬁliated Hospital of Gannan Medical University
OBJECTIVES The study is to investigate the effects of expression
downregulation in IKKa on high glucose-induced vascular endothelial
insulin resistance (IR) and dysfunction.
METHODS HUVECs were inoculated in a 6-well plate uniformly and
were randomly divided into four groups, namely, Control group, HG
group, Non- silencing shRNA group, and RNAi group, respectively.
Control group were only treated with DMEM containing glucose
(5.5 mmol/L) for 48h, while other groups were treated with DMEM
containing glucose (33 mmol/L) for 48h and insulin(100 nmol/L) for 30
minutes post transfection. The expression levels of IKKa mRNA and
protein, cell viability, NO and ET-1 level were detected.
RESULTS HUVECs were incubated in media containing 33mmol/L of
glucose for 48h and 100nmol/L of insulin for 30 minutes, the cell
viability was signiﬁcantly decreased, showing signiﬁcant difference
between HG group and Control group (P < 0.01); it was also found that
the levels of ET-1 was increased. however, the levels of NO was
decreased, which had signiﬁcant difference compared with Control
group (P < 0.05). Downregulation of IKKa expression by its gene-
silencing decreased the expression levels of IKKa mRNA and its
protein absolutely and may antagonize these changes in all above-
mentioned parameters induced by high glucose concentration and
insulin, and there was signiﬁcant difference between RNAi group and
HG group (P < 0.05). However, the results of the Non-silencing shRNA
group were similar to the High group and there was no signiﬁcant
difference between the two groups (P > 0.05).
CONCLUSIONS The silencing of IKKa gene could protect the HUVECs
in high glucose-induced vascular endothelial insulin resistance (IR)
and dysfunction.
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Danlou Tablet Decreases Cytokine IFN-g and Attenuates the Progression of
Atherosclerosis
Yanfen Chen,1 Minzhou Zhang,2 Shuai Mao,2 Lei Wang2
1The second clinical medical college, Guangzhou University of Chinese
Medicine; 2Intensive Care Unit, the second afﬁliated hospital,
Guangzhou University of Chinese Medicine
OBJECTIVES Atherosclerosis is an inﬂammatory disease in which
interferon (IFN)-g, the signature cytokine of Th1 cells, plays a central
role. We investigated whether Danlou Tablet, which promoting blood
circulation and eliminating phlegm in Traditional Chinese Medicine,
could decrease the expression of IFN-g or restain the Th1 cells acti-
vated to alleviate atherosclerosis in apolipoprotein E–deﬁcient
(ApoE-/-) mice.
METHODS Eight-week old ApoE-/-mice fed a high-fat diet for 16
weeks, at the mean time were randomly divided into six groups for 16-
wk. Control group that fed a chow diet and received no treatment,
other ﬁve groups fed a high-fat diet, model group that also received no
treatment, low-dose DLT group (1 g/kg/d), moderate-dose DLT
group(2g/kg/d), high-dose DLT group (4g/kg/d) were administered
Danlou Tablet suspension, and atorvastatin group that were treated
with atorvastatin. Cell suspensions were obtained from the spleens of
ﬁve randomly chosen mice from each group at the 16 week. The ﬂow
cytometry analysis were used to detect the percentages of CD4þ IFN-
gþ (Th1 cells) in the spleen cell suspensions. Immunohistochemical
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g from the aorta of ApoE-/-mice.
RESULTS Our results show that the percentages of CD4þ IFN-gþ from
the spleens were decreased after treatment with different dose of
Danlou Tablet groups compared to the model group, greatly decreased
with high-dose DLT group(model group vs DLT-H group :13.802.00
vs 8.231.65, p < 0.01). Immunohistochemical staining and real-time
PCR for aorta revealed that the IFN-g was decreaed with Danlou
Tablet dose-dependent(the fold changes of IFN-g:model group vs
DLT-L group: 2.960.87 vs 2.101.28, P < 0.05; model group vs DLT-M
group: 2.960.87 vs1.680.40, P < 0.01; model group vs DLT-H group:
2.960.87 vs1.240.15, P < 0.01). The ﬁndings suggest that Danlou
Tablet could markedly attenuates progression of atherosclerosis by
decreasing the expression of IFN-g and suppressing inﬂammation.
CONCLUSIONS Our ﬁndings demonstrate that Danlou Tablet could
decrease the expression of IFN-g or restain the artery-inﬁltrating T
cells, especially the Th1 cells activated or suppressed inﬂammation
and attenuated progression of atherosclerosis via weaken the Th1-
IFN-g pathway.
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Regulation and mechanism of Guizhi Decoction on Diabetic Cardiac
Autonomic Neuropathy
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OBJECTIVES To investigate the effects of Guizhi decoction (a long-
used harmonic prescription in traditional Chinesemedicine) on cardiac
autonomic neuropathy (CAN) in streptozotocin (STZ)-induced diabetic
rats. With the establishment of chemical sympathetic sprouting and
sympathectomy rat models, we explored the protective mechanism of
Guizhi decoction on the cardiac sympathetic remodeling.
METHODS
1) After induction of diabetic rats with STZ for four weeks, mecobalamin
and Guizhi decoction were administered to the STZ rats for 4 weeks.
Heart rate variability (HRV) were recorded, and contents of nerve
growth factor (NGF), growth associated protein 43(GAP-43) and
ciliary neurotrophic factor (CNTF) in myocardium as well as the
density of tyrosine hydroxylase (TH) and choline acetyltransferase
(ChAT) in the right atrium (RA) were respectively measured using
ELISA and immunohistochemical staining.
2) Cardiac sympathetic sprouting rats were induced with 4-Methyl-
catechol (4-MC) for 30 days. Metoprolol and Guizhi decoctions were
separately administered to the rats for 30 days. Meanwhile, we
established chemical sympathectomy rats with 6-Hydroxydopamine
(6-OHDA) for 3 days. Mecobalamin and Guizhi decoctions were
separately administered to the rats for 10 days. Contents of GAP-43,
TH and ChAT in the cardiac tissue were examined and distribution of
TH-positive nerve ﬁbers was observed. Besides, serum myocardial
enzyme levels and changes of myocardial morphology were observed
in 6-OHDA rats.
RESULTS
1) STZ rats demonstrated autonomic nerve dysfunction. Compared with
the model groups, rats treated with Guizhi decoction had higher HRV
parameters such as SDNN, RMSSD, LF, HF and TP, as well as
decreased LF/HF (P <0.05); the TH-positive nerve ﬁber decreased
while the ChAT-positive expression increased (P <0.05); contents of
GAP-43 and CNTF increased while NGF decreased (P <0.05). It sug-
gested that Guizhi decoction improved vagal nerve dysfunction in
STZ diabetic rats and mitigated the autonomic neuropathy.
2) 4-MC caused cardiac sympathetic sprouting. Compared with the
model group, contents of TH and GAP-43 in cardiac tissue decreased
while ChAT unchanged in Guizhi decoction group, indicating that
Guizhi decoction can effectively suppress the 4-MC-induced sympa-
thetic sprouting.
3) 6-OHDA caused chemical sympathectomy. Compared with the model
group, contents of TH and GAP-43 in myocardium of Guizhi decoction
group elevated and ChAT kept unchanged; the serum levels of
myocardial enzymes, the cardiac histopathology and heart function
were improved, suggesting that Guizhi decoction effectively allevi-
ated sympathetic injury and myocardial injury related to sympathetic
denervation.
CONCLUSIONS Guizhi decoction effectively alleviated diabetic CAN.
Guizhi decoction demonstrated double-sided regulation on cardiacsympathetic sprouting and sympathetic denervation which may be
one of the important mechanism of the improvement of Guizhi
Decoctionon on diabetic cardiomyopathy.
GW26-e4511
Blockade of Histone Demethylase JMJD2A Stimulates Endothelial Repair in
Denuded Aorta of diabetic Rat
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OBJECTIVES Endothelial dysfunction is a central hallmark of dia-
betes, delaying endothelial healing in diabetic patients following an-
gioplasty. The epigenetic abnormalities are increasingly considered to
be relevant to the pathogenesis of diabetic complications. We here
investigated the therapeutic potential of histone demethylase JMJD2A
and its substrate histone H3 lysine 9 trimethylation (H3K9me3) on re-
endothelialization in a vascular injury model of diabetic rats.
METHODS JMJD2A inhibition was achieved either by chemical in-
hibitor 2,4-pyridinedicarboxylic acid (2,4-PDCA) or small interfering
RNA (siRNA) both in vitro and in vivo studies. In vitro, we examined
the proliferative, migratory and angiogenic capacities of human um-
bilical vein endothelial cells (HUVECs) in response to high glucose
(HG). Flow cytometry was performed to detect the apoptosis and the
expressions of apoptosis-associated genes were assessed by real-time
PCR and western blot. Immunoprecipitation (ChIP) assay was con-
ducted to examine the modiﬁcation of H3K9me3 at related genes’
promoters. In vivo, common carotid artery balloon injury was devel-
oped in high-fat diets (60% fat) and low-dose streptozotocin (35 mg/
kg) induced diabetic rats. The reendothelialization was quantiﬁed
withEvens blue staining and immunohistochemical staining.
RESULTS Both in HG-treated HUVECs and balloon–injured arteries of
diabetic rats, the global expression of JMJD2A was increased whereas
H3K9me3 was decreased. In vitro, JMJD2A inhibition either by 2,4-
PDCA (0.5mM) or by siRNA (20nM) accelerated HUVECs proliferation,
migration and tube formation in response to HG, accompanied by
reduced expression of TNF-a and suppressed apoptosis (down-
regulated caspase3, caspase9, Bax and upregulated Bcl-2). ChIP assay
indicated that the potential mechanism was relevant to the increased
H3K9me3 at the promoter of TNF-a and then the transcriptional
silencing of TNF-a. Complementary in vitro studies showed that
JMJD2A inhibition promoted reendothelialization in diabetic rats.
CONCLUSIONS JMJD2A inhibition promotes reendothelialization af-
ter arterial injury in diabetic rats via accelerated proliferation,
migration and suppressed apoptosis of endothelial cells.
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Pioglitazone Decreases Plaque Thrombosis by Attenuating Plaque
Inﬂammation. An In Vivo Study Using 18F-FDG PET/CT
Quanming Zhao, Mingduo Zhang, Xin Zhao, Tingting Feng
Beijing Anzhen Hospital, Capital Medical University
OBJECTIVES Pioglitazone, a clinically used insulin sensitizer, has
appeared to have an anti-atherosclerotic effect. The aims of this study
is to determine whether pioglitazone can reduce the number of plaque
thrombosis incidences and whether decreasing plaque inﬂammation
is the mechanism by which pioglitazone reduces plaque thromboses
in an atherosclerotic model.
METHODS 20 male New Zealand white rabbits were randomly divided
into two groups: Atherosclerosis group (Group A, n¼10) and middle-
pioglitazone-treated group (Group P, n¼10). Atherosclerosis was
induced in all rabbits by intermittent high-cholesterol diet and
endothelial denudation. From the ninth week, the rabbits in group P
received pioglitazone (10 mg$kg-1$d-1) in addition to the diet, till the
end of experiment. PET/CT scans were performed at 8 week and 18
week in all survival rabbits, to obtain FDG uptake parameters (mean
standardized uptake value, SUVmean and maximal standardized up-
take value, SUVmax). Concomitantly, serum samples were obtained
for analysis of blood glucose (G), triglycerides (TG), total cholesterol
(Ch), HDL, LDL, hs-CRP and matrix metalloproteinase-9 concentration
(MMP-9). All survival rabbits underwent 2 pharmacological triggerings
to induce plaque rupture at 18 week. After pharmacological triggering,
all rabbits were euthanatized, aortic histopathological analysis were
performed.
RESULTS 20 male New Zealand white rabbits were randomly
divided into two groups: Atherosclerosis group (Group A, n¼10) and
